D.E. Shaw & Co
CME icon

D.E. Shaw & Co’s CME Group CME Stock Holding History

D.E. Shaw & Co’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40.7M Sell
137,862
-13,067
-9% -$3.88M 0.02% 748
2025
Q4 		$41.2M Sell
150,929
-35,472
-19% -$9.64M 0.02% 813
2025
Q3 		$50.4M Sell
186,401
-32,536
-15% -$8.85M 0.03% 653
2025
Q2 		$60.3M Sell
218,937
-93,891
-30% -$25.5M 0.04% 502
2025
Q1 		$83M Sell
312,828
-31,893
-9% -$7.87M 0.07% 326
2024
Q4 		$80.1M Sell
344,721
-654,501
-66% -$151M 0.06% 399
2024
Q3 		$220M Buy
999,222
+573,180
+135% +$119M 0.19% 118
2024
Q2 		$83.8M Buy
426,042
+171,655
+67% +$35.5M 0.08% 303
2024
Q1 		$54.8M Sell
254,387
-152,634
-38% -$32.1M 0.05% 448
2023
Q4 		$85.7M Sell
407,021
-353,211
-46% -$75.4M 0.07% 315
2023
Q3 		$152M Sell
760,232
-169,839
-18% -$33.8M 0.16% 136
2023
Q2 		$172M Sell
930,071
-315,765
-25% -$58.4M 0.18% 117
2023
Q1 		$239M Sell
1,245,836
-403,271
-24% -$72.9M 0.26% 60
2022
Q4 		$277M Buy
1,649,107
+1,122,449
+213% +$195M 0.31% 36
2022
Q3 		$93.3M Buy
526,658
+313,361
+147% +$61.9M 0.11% 185
2022
Q2 		$43.7M Buy
213,297
+81,424
+62% +$17.3M 0.05% 458
2022
Q1 		$31.4M Buy
131,873
+10,975
+9% +$2.58M 0.03% 729
2021
Q4 		$27.6M Sell
120,898
-390,728
-76% -$86M 0.02% 874
2021
Q3 		$98.9M Buy
511,626
+359,810
+237% +$72.9M 0.09% 261
2021
Q2 		$32.3M Sell
151,816
-13,143
-8% -$2.77M 0.03% 766
2021
Q1 		$33.7M Sell
164,959
-670,499
-80% -$132M 0.03% 666
2020
Q4 		$152M Sell
835,458
-958,750
-53% -$163M 0.14% 150
2020
Q3 		$300M Buy
1,794,208
+140,503
+8% +$23.7M 0.31% 46
2020
Q2 		$269M Buy
1,653,705
+1,172,381
+244% +$210M 0.32% 45
2020
Q1 		$83.2M Buy
481,324
+257,311
+115% +$51.2M 0.13% 168
2019
Q4 		$45M Buy
224,013
+18,218
+9% +$3.74M 0.05% 440
2019
Q3 		$43.5M Sell
205,795
-36,671
-15% -$7.66M 0.05% 427
2019
Q2 		$47.1M Sell
242,466
-754,477
-76% -$139M 0.06% 398
2019
Q1 		$164M Buy
996,943
+834,516
+514% +$148M 0.21% 95
2018
Q4 		$30.6M Buy
162,427
+11,249
+7% +$2.08M 0.04% 513
2018
Q3 		$25.7M Sell
151,178
-100,699
-40% -$17M 0.03% 661
2018
Q2 		$41.3M Sell
251,877
-128,463
-34% -$21M 0.05% 432
2018
Q1 		$61.5M Buy
380,340
+14,797
+4% +$2.36M 0.08% 290
2017
Q4 		$53.4M Sell
365,543
-154,721
-30% -$22M 0.07% 332
2017
Q3 		$70.6M Sell
520,264
-86,891
-14% -$11M 0.11% 225
2017
Q2 		$76M Sell
607,155
-195,625
-24% -$23.4M 0.13% 192
2017
Q1 		$95.4M Buy
802,780
+447,652
+126% +$53.8M 0.17% 137
2016
Q4 		$41M Sell
355,128
-556,138
-61% -$61.9M 0.07% 364
2016
Q3 		$95.2M Sell
911,266
-655,402
-42% -$68.4M 0.17% 133
2016
Q2 		$153M Buy
1,566,668
+190,465
+14% +$18M 0.28% 68
2016
Q1 		$132M Buy
1,376,203
+159,074
+13% +$14.5M 0.24% 92
2015
Q4 		$110M Sell
1,217,129
-362,579
-23% -$34.1M 0.16% 142
2015
Q3 		$147M Buy
1,579,708
+416,628
+36% +$39.6M 0.22% 101
2015
Q2 		$108M Buy
1,163,080
+285,908
+33% +$26.7M 0.16% 138
2015
Q1 		$83.1M Buy
877,172
+599,000
+215% +$55.5M 0.13% 171
2014
Q4 		$24.7M Buy
278,172
+101,369
+57% +$8.59M 0.03% 619
2014
Q3 		$14.1M Sell
176,803
-316,787
-64% -$23.9M 0.02% 882
2014
Q2 		$35M Sell
493,590
-453,371
-48% -$31.9M 0.05% 440
2014
Q1 		$70.1M Buy
946,961
+577,405
+156% +$43.6M 0.1% 209
2013
Q4 		$29M Buy
369,556
+234,520
+174% +$18.4M 0.04% 501
2013
Q3 		$9.98M Sell
135,036
-53,902
-29% -$3.97M 0.02% 1012
2013
Q2 		$14.4M Buy
+188,938
New +$12.4M 0.03% 684

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

D.E. Shaw & Co's CME Position: Q1 2026 in Review

D.E. Shaw & Co reduced its CME Group (CME) stake by 8.7% in Q1 2026, selling an estimated $3.88M and leaving 137,862 shares worth $40.7M. The position accounts for 0.02% of the portfolio, ranked #748.

D.E. Shaw & Co first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $300M in Q3 2020. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • D.E. Shaw & Co held 137,862 shares of CME Group worth $40.7M as of Q1 2026.
  • D.E. Shaw & Co sold 13,067 CME Group shares in Q1 2026, an estimated $3.88M.
  • CME Group made up 0.02% of D.E. Shaw & Co's portfolio in Q1 2026, its #748 holding.
  • D.E. Shaw & Co first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • D.E. Shaw & Co's CME Group position peaked at $300M in Q3 2020.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.